SCHEMBL6700787

SCHEMBL6700787

Cc1ccc(C)n1-c1cccc(-c2ccc(-c3cccnc3)cc2)n1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 5/20 0.53
CYP3A4 P08684 2/20 0.43
KIF11 P52732 1/20 0.43
ALDH1A1 P00352 1/20 0.43
CYP1A2 P05177 1/20 0.43
KDR P35968 2/20 0.41
EPHB4 P54760 1/20 0.41
MAP3K5 Q99683 1/20 0.41
KARS1 Q15046 1/20 0.40
CYP2E1 P05181 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2B6 P20813 1/20 0.40
CYP11B2 P19099 2/20 0.40
CYP19A1 P11511 2/20 0.40
MKNK1 Q9BUB5 1/20 0.40
MKNK2 Q9HBH9 1/20 0.40
CYP17A1 P05093 1/20 0.40
CYP11B1 P15538 1/20 0.40
TEK Q02763 1/20 0.39
APP P05067 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2969912 0.81 RAB9A (0.54) ALDH1A1
SCHEMBL6696955 0.77 RAB9A (0.42) ALDH1A1APP
SCHEMBL6701320 0.75 KDM4E (0.37) CYP2A6ALDH1A1CYP11B1
SCHEMBL9848050 0.75 MAPT (0.47) CYP3A4ALDH1A1CYP1A2CYP2C9APP
SCHEMBL6618761 0.74 KDM4E (0.38) CYP2A6ALDH1A1CYP11B1
SCHEMBL12339136 0.73 CYP2A6 (0.69) CYP2A6CYP3A4ALDH1A1CYP1A2KDR
SCHEMBL6621303 0.72 KDM4E (0.50) ALDH1A1
SCHEMBL12925590 0.72 CYP19A1 (0.68) CYP2A6CYP3A4ALDH1A1CYP1A2KARS1
SCHEMBL6618175 0.71 NOS1 (0.36) ALDH1A1
SCHEMBL6618202 0.71 IRAK4 (0.40) CYP2A6ALDH1A1CYP1A2KARS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040229911-A1 New pharmaceutical combinations for NOS inhibitors PFIZER INC 2004-11-18 US disclosed
US-20040142924-A1 6-Phenylpyridyl-2-amine derivatives useful as NOS inhibitors PFIZER INC 2004-07-22 US disclosed
EP-0946512-B1 6-PHENYLPYRIDYL-2-AMINE DERIVATIVES USEFUL AS NOS INHIBITORS PFIZER (US) 2003-10-08 EP disclosed
US-20020103227-A1 6-Phenylpyridyl-2-amine derivatives useful as NOS inhibitors LOWE JOHN A (US) 2002-08-01 US disclosed
US-20020032191-A1 6-phenylpyridyl-2-amine derivatives useful as NOS inhibitors LOWE JOHN A (US) 2002-03-14 US disclosed
US-6235750-B1 NITRIC OXIDE SYNTHASE INHIBITOR PFIZER INC 2001-05-22 US disclosed
EP-0946512-A1 6-PHENYLPYRIDYL-2-AMINE DERIVATIVES USEFUL AS NOS INHIBITORS PFIZER INC. (US) 1999-10-06 EP disclosed
WO-1998024766-A1 6-PHENYLPYRIDYL-2-AMINE DERIVATIVES USEFUL AS NOS INHIBITORS PFIZER INC. (US) 1998-06-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020032191-A1 6-phenylpyridyl-2-amine derivatives useful as NOS inhibitors NOS1, NOS2, NOS3 CYP2A6 126/4885CYP3A4 259/4885KIF11 4769/4885
US-20040142924-A1 6-Phenylpyridyl-2-amine derivatives useful as NOS inhibitors NOS1, NOS2, NOS3 CYP2A6 126/4885CYP3A4 259/4885KIF11 4769/4885
US-20040229911-A1 New pharmaceutical combinations for NOS inhibitors NOS1, NOS3, NPBWR1 CYP2A6 1730/4885CYP3A4 1170/4885KIF11 898/4885
US-20020103227-A1 6-Phenylpyridyl-2-amine derivatives useful as NOS inhibitors NOS1, NOS2, NOS3 CYP2A6 126/4885CYP3A4 259/4885KIF11 4769/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.